Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 29:18:11925-11934.
doi: 10.2147/JIR.S534657. eCollection 2025.

Assessment of the Anti-Inflammatory Efficacy and Symptom Resolution Time of Kangfuxin Liquid Combined with Metronidazole in Recurrent Oral Ulcers

Lu Shen #  1 , Xingyue Chen #  1 , Ting Zhang  1
Affiliations

Assessment of the Anti-Inflammatory Efficacy and Symptom Resolution Time of Kangfuxin Liquid Combined with Metronidazole in Recurrent Oral Ulcers

Lu Shen et al. J Inflamm Res. .

Abstract

Objective: To evaluate the clinical efficacy and inflammatory modulation potential of Kangfuxin Liquid (KFXY; a traditional Chinese medicine recovery solution) in combination with metronidazole (MTZ) for the treatment of recurrent oral ulcers (ROU).

Methods: A retrospective cohort study was conducted using clinical data from 117 ROU patients admitted between January 2021 and January 2023. Patients were categorized into two groups: a control group (n=58) treated with MTZ oral adhesive patches alone, and an observation group (n=59) receiving KFXY plus MTZ. Primary outcomes included clinical response rates, symptom resolution time (ulcer healing, pain relief, and eating ability), systemic inflammatory biomarkers (C-reactive protein [CRP], tumor necrosis factor-alpha [TNF-α], interleukin-6 [IL-6]), oral microbial flora composition (Veillonella, Streptococcus), and adverse event incidence.

Results: Clinical Efficacy: The observation group demonstrated a significantly higher total response rate (94.92% vs 79.31%; P<0.05). Symptom Resolution: The KFXY-MTZ combination accelerated ulcer healing (P<0.05), reduced pain intensity (P<0.05), and improved oral intake (P<0.05) compared to MTZ alone. Inflammatory Modulation: Pre-treatment CRP, TNF-α, and IL-6 levels were comparable (P>0.05); post-treatment, these biomarkers were significantly lower in the observation group (P<0.05). Microbial Flora: Post-treatment levels of Veillonella and Streptococcus were significantly elevated in the observation group (P<0.05), indicating potential probiotic effects. Safety: Adverse event rates were similar between groups (control: 5.17%; observation: 6.78%; P>0.05).

Conclusion: The KFXY-MTZ combination therapy exhibits robust anti-inflammatory and probiotic activities, accelerating ROU healing without compromising safety. These findings support its clinical utility as an integrative treatment strategy for ROU.

Keywords: Kangfuxin liquid; Metronidazole; effectiveness; recurrent oral ulcers; timeliness.

PubMed Disclaimer

Conflict of interest statement

The authors report no conflicts of interest in this work.

Figures

Figure 1
Figure 1
Comparison of Improvement in Clinical Symptoms.
Figure 2
Figure 2
Comparison of Inflammatory Factor Levels.
Figure 3
Figure 3
Comparison of Oral Microbial Index Levels (copies/mL).
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Fitzpatrick SG, Cohen DM, Clark AN. Ulcerated lesions of the oral mucosa: clinical and histologic review. Head Neck Pathol. 2019;13(1):91–102. doi: 10.1007/s12105-018-0981-8 - DOI - PMC - PubMed
    1. Bilodeau EA, Lalla RV. Recurrent oral ulceration: etiology, classification, management, and diagnostic algorithm. Periodontol 2000. 2019;80(1):49–60. doi: 10.1111/prd.12262 - DOI - PubMed
    1. Kaur R, Behl AB, Punia RS, Nirav K, Singh KB, Kaur S. Assessment of prevalence of recurrent aphthous stomatitis in the north indian population: a cross-sectional study. J Pharm Bioallied Sci. 2021;13(Suppl 1):S363–S366. doi: 10.4103/jpbs.JPBS_581_20 - DOI - PMC - PubMed
    1. Dudding T, Haworth S, Lind PA, et al. Genome wide analysis for mouth ulcers identifies associations at immune regulatory loci. Nat Commun. 2019;10(1):1052. doi: 10.1038/s41467-019-08923-6 - DOI - PMC - PubMed
    1. Isher DK, Behl AB, Singh A, Isher PPS, Kaur G, Kaur H. Prevalence of recurrent aphthous ulcers (RAUs) in the population of Ludhiana. J Indian Acad Oral Med Radiol. 2022;34(4):437–441. doi: 10.4103/jiaomr.jiaomr_86_21 - DOI

LinkOut - more resources